Novo’s Ozempic Linked to Lower Dementia Rate in Oxford Study - Bloomberg

0

12.07.2024 11:05

Google.com 

1. Novo’s Ozempic Linked to Lower Dementia Rate in Oxford Study  Bloomberg
2. Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study  FiercePharma
3. Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong Study  Investor's Business Daily
4. Pharmalittle: We're reading about a study of Ozempic and dementia, smaller PBMs, and more  STAT
5. Ozempic could cut the risk of dementia by half, Oxford study suggests  The Telegraph

Moscow.media

Частные объявления сегодня

Rss.plus

Все новости за 24 часа